|
1
|
Karsenty G and Wangner EF: Reaching a
genetic and molecular understanding of skeletal development. Dev
Cell. 2:389–406. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kular J, Tickner J, Chim SM and Xu J: An
overview of the regulation of bone remodeling at cellular level.
Clin Biochem. 45:863–873. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Khan SN, Bostrom MP and Lane JM: Bone
growth factors. Orthop Clin North Am. 31:375–388. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lieberman JR, Daluiski A and Einhorn TA:
The role of growth factors in the repair of bone. Biology and
clinical applications. J Bone Joint Surg Am. 84-A:1032–1044. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Reddi AH, Roodman D, Freeman C and Mohla
S: Mechanisms of tumor metastasis to the bone: Challenges and
opportunities. J Bone Miner Res. 18:190–194. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Schneider MR, Sibilia M and Erben RC: The
EGFR network in bone biology and pathology. Trends Endocrinol
Metab. 20:517–524. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kumegawa M, Hiramatsu M, Hatakeyama K,
Yajima T, Kodama H, Osaki T and Kurisu K: Effects of epidermal
growth factor on osteoblastic cells in vitro. Calcif Tissue Int.
35:542–548. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hata R, Hori H, Nagai Y, Tanaka S, Kondo
M, Hiramatsu M, Utsumi N and Kumegawa M: Selective inhibition of
type 1 collagen synthesis in osteoblastic cells by epidermal growth
factor. Endocrinology. 115:867–876. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ng KW, Partridge NC, Niall M and Martin
TJ: Stimulation of DNA synthesis by epidermal growth factor in
osteoblast-like cells. Calcif Tissue Int. 35:624–628. 1983.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fang MA, Kujubu DA and Hahn TJ: The
effects of prostaglandin E2, parathyroid hormone, and epidermal
growth factor on mitogenesis, signaling, and primary response genes
in UMR 10601 osteoblast-like cells. Endocrinology. 131:2113–2119.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Vukicevic S, Kleinman HK, Luyten FP, Roche
AB and Reddi AH: Identification of multiple active growth factors
in basement membrane Matrigel suggests caution in interpretation of
cellular activity related to extracellular matrix components. Exp
Cell Res. 202:1–8. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhu J, Siclari VA, Liu F, Spatz JM,
Chandra A, Divieti Pajevic P and Qin L: Amphiregulin-EGFR signaling
mediates the migration of bone marrow mesenchymal progenitors
toward PTH-stimulated osteoblasts and osteocytes. PLoS One.
7:e500992012. View Article : Google Scholar
|
|
13
|
Kawabata T, Tokuda H, Fujita K, Kainuma S,
Sakai G, Matsushima-Nishiwaki R, Kozawa O and Otsuka T: Resveratrol
inhibits the epidermal growth factor-induced migration of
osteo-blasts: The suppression of SAPK/JNK and Akt. Cell Physiol
Biochem. 43:1025–1036. 2017. View Article : Google Scholar
|
|
14
|
Jankun J, Selman SH, Wiercz RS and
Skrzypczak-Jankun E: Why drinking green tea could prevent cancer.
Nature. 387:5611997. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Koo SH and Montminy M: In vino veritas: A
tale of two sirt1s. Cell. 127:1091–1093. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
George SE, Ramalakshmi K and Mohan Rao LJ:
A perception on health benefits of coffee. Crit Rev Food Sci Nutr.
48:464–486. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Thielecke F and Boschmann M: The potential
role of green tea catechins in the prevention of the metabolic
syndrome-a review. Phytochemistry. 70:11–24. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shimizu M, Adachi S, Masuda M, Kozawa O
and Moriwaki H: Cancer chemoprevention with green tea catechins by
targeting receptor tyrosine kinases. Mol Nutr Food Res. 55:832–843.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shen CL, Yeh JK, Cao JJ and Wang JS: Green
tea and bone metabolism. Nutr Res. 29:437–456. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Folwarczna J, Pytlik M, Zych M, Cegieła U,
Nowinska B, Kaczmarczyk-Sedlak I, Sliwinski L, Trzeciak H and
Trzeciak HI: Effects of caffeic and chlorogenic acids on the rat
skeletal system. Eur Rev Med Pharmacol Sci. 19:682–693.
2015.PubMed/NCBI
|
|
21
|
Kwak SC, Lee C, Kim JY, Oh HM, So HS, Lee
MS, Rho MC and Oh J: Chlorogenic acid inhibits osteoclast
differentiation and bone resorption by downregulation of receptor
activator of nuclear factor kappaB ligand-induced nuclear factor of
activated T cells c1 expression. Biol Pharm Bull. 36:1779–1786.
2013. View Article : Google Scholar
|
|
22
|
Singh R, Akhtar N and Haqqi TM: Green tea
polyphenol epigal-locatechin-3-gallate: Inflammation and arthritis.
[Corrected]. Life Sci. 86:907–918. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sudo H, Kodama H, Amagai Y, Yamamoto S and
Kasai S: In vitro differentiation and calcification in a new clonal
osteogenic cell line derived from newborn mouse calvaria. J Cell
Biol. 96:191–198. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kozawa O, Tokuda H, Miwa M, Kotoyori J and
Oiso Y: Cross-talk regulation between cyclic AMP production and
phosphoinositide hydrolysis induced by prostaglandin E2
in osteoblast-like cells. Exp Cell Res. 198:130–134. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Karagiosis SA, Chrisler WB, Bollinger N
and Karin NJ: Lysophosphatidic acid-induced ERK activation and
chemotaxis in MC3T3-E1 preosteoblasts are independent of EGF
receptor transactivation. J Cell Physiol. 219:716–723. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Laemmli UK: Cleavage of structural
proteins during the assembly of the head of bacteriophage T4.
Nature. 227:680–685. 1970. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kato K, Ito H, Hasegawa K, Inaguma Y,
Kozawa O and Asano T: Modulation of the stress-induced synthesis of
hsp27 and αB-crystallin by cyclic AMP in C6 rat glioma cells. J
Neurochem. 66:946–950. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yang CS, Chen LS, Lee ML, Balentine D, Kuo
MC and Schantz SP: Blood and urine levels of tea catechins after
ingestion of different amounts of green tea by human volunteers.
Cancer Epidemiol Biomark Prev. 7:351–354. 1998.
|
|
29
|
Liu JS, Chen SH, Lin CL, Tsai SH and Liang
YC: Inhibition of melanoma growth and metastasis by combination
with (−)-epigal-locatechin-3-gallate and dacarbazine in mice. J
Cell Biochem. 83:631–642. 2001. View
Article : Google Scholar
|
|
30
|
Siddiqui IA, Malik A, Adhami VM, Asim M,
Hafeez BB, Sarfaraz S and Mukhtar H: Green tea polyphenol EGCG
sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated
apoptosis and synergistically inhibits biomarkers associated with
angiogenesis and metastasis. Oncogene. 27:2055–2063. 2008.
View Article : Google Scholar
|
|
31
|
Shankar S, Ganapathy S, Hingorani SR and
Srivastava RK: EGCG inhibits growth, invasion, angiogenesis and
metastasis of pancreatic cancer. Front Biosci. 13:440–452. 2008.
View Article : Google Scholar
|
|
32
|
Singh AK, Seth P, Anthony P, Husain MM,
Madhavan S, Mukhtar H and Maheshwari RK: Green tea constituent
epigal-locatechin-3-gallate inhibits angiogenic differentiation of
human endothelial cells. Arch Biochem Biophys. 401:29–37. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mah YJ, Song JS, Kim SO, Lee JH, Jeon M,
Jung UW, Moon SJ, Kim JH and Choi HJ: The effect of
epigallocatechin-3-gallate (EGCG) on human alveolar bone cells both
in vitro and in vivo. Arch Oral Biol. 59:539–549. 2014. View Article : Google Scholar : PubMed/NCBI
|
